Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management
HemaSphere · 2026-06 · 10 (6)
DOI: 10.1002/hem3.70404 ↗Kurz gefasst
Leserbrief in der Zeitschrift HemaSphere, online erschienen am 15.06.2026. Verfasst von Jan-Michael Werner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany.
- Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany.
- Institute of Neuroscience and Medicine (INM-3, INM-4) Research Center Juelich Juelich Germany.
- Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany.
ORCID-Profile: Jan-Michael Werner, Norbert Galldiks, Michael Schroeter, Ruth Flümann, Gilbert Wunderlich, Gereon R Fink, Oezguer A Onur, Tim Richardson
Zitieren
APA
Werner, J. M., Gödel, P., Galldiks, N., Krone, C., Schroeter, M., Holtick, U., Flümann, R., Wunderlich, G., Hallek, M., Fink, G. R., Scheid, C., Onur, O. A., & Richardson, T. (2026). Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management. HemaSphere, 10(6). https://doi.org/10.1002/hem3.70404
Vancouver
Werner JM, Gödel P, Galldiks N, Krone C, Schroeter M, Holtick U, et al. Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management. HemaSphere. 2026;10(6). doi:10.1002/hem3.70404
BibTeX
@article{Werner2026,
author = {Werner, Jan-Michael and Gödel, Philipp and Galldiks, Norbert and Krone, Christopher and Schroeter, Michael and Holtick, Udo and Flümann, Ruth and Wunderlich, Gilbert and Hallek, Michael and Fink, Gereon R and Scheid, Christoph and Onur, Oezguer A and Richardson, Tim},
title = {Non‐ICANS neurotoxicity after BCMA‐directed CAR‐T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co‐management},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {6},
doi = {10.1002/hem3.70404}
}
EUVIMED